SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Tokyo VD who wrote (5873)10/14/1998 10:50:00 AM
From: Linda Kaplan  Read Replies (1) | Respond to of 7041
 
Ah. That is a huge downgrade in sales expectations! Wow. I suppose that leaves about 50 cents for ZONA? By the way, the Hambrecht and Quist fellow on CNBC this morning said something like something I said to Nancy the other day. He said that these drugs have higher sales in the beginning and then lower. Did you hear him, by the way? It was interesting.

--Linda



To: Tokyo VD who wrote (5873)10/14/1998 11:53:00 AM
From: dino  Read Replies (2) | Respond to of 7041
 
Tokyo VD.....Viagra a $500 mil. drug ULTIMATELY.....

I think you are 100% correct although not in the near future. I do not feel that Vasomax, due out next year, will reduce sales to this level.....but certainly a more advanced oral version that has equivalent to better efficacy and less side effects will reduce Viagra's future sales potential.

Viagra's soft sales I'm sure are caused by multiple factors including side effect issues.

Linda - Zonagen to break $10 today.....GET REAL!!! OK, I think it will break $100 tomorrow........this is fun!!!!